CVC Capital Acquisitions: How CVC Built Its Business Through M&A

CVC Capital Acquisitions show how one of the world’s major private equity and investment advisory firms used buyouts to build exposure across food and beverage, manufacturing, healthcare, financial services, food processing, insurance, education, telecommunications, consumer goods, asset management, consulting, and medical services.

Between 2000 and 2025, CVC Capital Partners made 48 acquisitions with a total disclosed deal value of about $71.6 billion. The average disclosed deal size was approximately $1.5 billion, showing a strategy built around large platform investments as well as targeted sector-specific deals.

The firm’s acquisition activity has focused mainly on food and beverage and manufacturing, with 9 deals each. Healthcare accounted for 8 deals, financial services accounted for 6 deals, and food processing accounted for 5 deals. That mix reflects CVC Capital Partners’ role as an investment advisory firm managing private equity, asset, credit, and infrastructure strategies.

The most recent listed acquisition was Grupo GSH, acquired in April 2025 for $272.0 million. Grupo GSH operates a specialized network in highly complex hemotherapy and cell therapy, strengthening CVC’s healthcare exposure.

What Is CVC Capital Partners?

CVC Capital Partners is an investment advisory firm that manages private equity, asset, credit, and infrastructure strategies. As a private equity investor, CVC does not acquire companies in the same way an operating company might.

A corporate acquirer usually buys companies to integrate them into one business. A private equity firm buys companies as investments. It typically looks for businesses that can grow, improve margins, expand internationally, consolidate markets, professionalize operations, or become more valuable under focused ownership.

That distinction is important when analyzing CVC Capital Acquisitions. The firm’s acquisitions do not all belong to one product line. Instead, they reflect investment theses across different sectors.

The listed deals include tea businesses, pasta companies, spirits producers, insurance platforms, asset managers, universities, healthcare businesses, cosmetics and personal care assets, telecom towers, cash management, consulting firms, and complex medical services.

This is a diversified private equity strategy. Yet the logic behind many deals is consistent: CVC often targets businesses with recognizable brands, strong market positions, recurring demand, scale potential, or room for operational improvement.

Why CVC Capital Acquisitions Matter

CVC Capital Acquisitions matter because they show how private equity firms deploy capital across essential consumer, healthcare, financial, and infrastructure-linked sectors.

The acquisition record shows several major themes.

First, food and beverage has been a major focus. Ekaterra, Lipton, Stock Spirits Group, Panzani, Vivartia, and La Piadineria show CVC’s interest in consumer food, beverages, restaurants, tea, pasta, spirits, and food production.

Second, healthcare has been a recurring theme. Grupo GSH, Therakos, Spectrum Medical, Cooper, and Universidad Alfonso X El Sabio all show exposure to healthcare services, medical products, pharmaceuticals, education, and complex therapies.

Third, financial services have been important. Affin Hwang Asset Management, CFGI, Ethniki Insurance, RiverStone Europe, Hermes, and related financial services deals show CVC’s interest in asset management, insurance, consulting, risk management, and financial infrastructure.

Fourth, manufacturing and consumer products remain core. Ekaterra, Lipton, Cooper, Shiseido’s Personal Care Business, and Panzani all reflect exposure to branded or manufactured products.

Fifth, the firm has invested in infrastructure and digital-adjacent assets. Irrawaddy Green Towers added telecommunications tower exposure, while Multiversity Group added digital education and e-learning.

The overall pattern shows a private equity firm using M&A to build large, sector-diverse platforms with clear commercial demand.

Full List of CVC Capital Acquisitions

CVC Capital Acquisitions Timeline

2000–2018: Building a Global Buyout Platform

CVC Capital Partners’ listed acquisition activity spans from 2000 to 2025. While the visible recent record begins in 2019, the broader acquisition count shows a long-running buyout strategy across multiple economic cycles.

The firm’s total disclosed deal value of about $71.6 billion across 48 acquisitions reflects a private equity platform with the ability to pursue large transactions across consumer goods, healthcare, financial services, manufacturing, and infrastructure-linked markets.

This long history matters because private equity success depends on more than one deal. It depends on repeatable sector judgment, capital discipline, portfolio management, operating improvement, and exit planning.

2019: Education and Advisory Services

In 2019, CVC acquired Universidad Alfonso X El Sabio and Teneo.

Universidad Alfonso X El Sabio, acquired for $1.3 billion, is a private university offering education in healthcare, socioeconomics, and the sciences. Teneo, acquired for $350.0 million, provides advisory services including strategic communications, investor relations, and financial transaction support.

These deals show CVC investing in knowledge-based businesses. Education and advisory services can be attractive when supported by strong brands, professional expertise, and institutional demand.

2020: Insurance, Food Production, Telecom Towers, and Cash Management

The year 2020 was active for CVC. The firm acquired Hermes, Vivartia, RiverStone Europe, and Irrawaddy Green Towers.

Hermes added cash management and security exposure in Peru. Vivartia added a food production conglomerate in Greece. RiverStone Europe added insurance run-off solutions. Irrawaddy Green Towers added telecom tower infrastructure exposure in Myanmar.

These acquisitions show the diversity of CVC’s investment model. The firm backed businesses in financial infrastructure, food production, insurance, and telecommunications infrastructure within the same year.

2021: Food, Financial Services, Healthcare Products, Education, and Consumer Goods

The year 2021 was one of the most important periods in the listed CVC acquisition record. The firm acquired Shiseido’s Personal Care Business, Cooper, Ethniki Insurance, Panzani, Stock Spirits Group, CFGI, Multiversity Group, Ekaterra, and Lipton.

This year alone shows several major sector themes.

Cooper added OTC drug manufacturing and distribution. Shiseido’s Personal Care Business added affordable skincare products. Ethniki Insurance added insurance exposure. Panzani added pasta, rice, sauces, couscous, and semolina. Stock Spirits Group added spirits. CFGI added corporate finance consulting. Multiversity Group added digital education. Ekaterra and Lipton added major tea and beverage exposure.

The concentration of deals in 2021 shows CVC’s appetite for platform investments across consumer, healthcare, education, financial, and food categories.

2022: Healthcare Systems and Asset Management

In 2022, CVC acquired Affin Hwang Asset Management and Spectrum Medical.

Affin Hwang Asset Management, acquired for $368.0 million, provides investment solutions for organizations. Spectrum Medical, acquired for $1.2 billion, is a global leader in perfusion systems and EMR systems.

These acquisitions added exposure to financial services and healthcare technology. Spectrum Medical was especially important because perfusion and medical system platforms serve specialized clinical needs.

2024: Food Service and Immune Modulation Therapy

In 2024, CVC acquired La Piadineria and Therakos.

La Piadineria, acquired for $657.0 million, operates in the Italian restaurant market with freshly made piadina. Therakos, acquired for $925.0 million, provides extracorporeal photopheresis immune modulation therapy.

These deals show CVC investing in both consumer food service and specialized healthcare. La Piadineria fits the food and beverage theme, while Therakos fits the medical and healthcare theme.

2025: Complex Hemotherapy and Cell Therapy Through Grupo GSH

In 2025, CVC acquired Grupo GSH for $272.0 million. Grupo GSH operates a specialized network in highly complex hemotherapy and cell therapy.

This was the most recent listed acquisition. It continued CVC’s healthcare investment theme, especially in complex treatment networks and specialized medical services.

The deal also reflects growing private equity interest in healthcare platforms that combine specialized expertise, infrastructure, and recurring clinical demand.

Biggest CVC Capital Acquisitions by Deal Value

The largest deals show CVC’s preference for scaled platforms. Food and beverage, consumer health, consulting, education, healthcare technology, spirits, and insurance all appear among the biggest listed acquisitions.

Most Common Acquisition Categories

This category mix confirms that CVC Capital Acquisitions are diversified but concentrated in large, investable sectors with recurring demand and platform-building potential.

Strategic Lessons From CVC Capital Acquisitions

Food and Beverage Is a Major Platform Theme

CVC has made multiple acquisitions in food and beverage, including Ekaterra, Lipton, Stock Spirits Group, Panzani, Vivartia, and La Piadineria.

These businesses can be attractive because they often have recognized brands, distribution networks, consumer loyalty, and market expansion potential.

Healthcare Is a Long-Term Focus

Grupo GSH, Therakos, Spectrum Medical, Cooper, and Universidad Alfonso X El Sabio all show healthcare exposure. CVC has invested in therapy platforms, medical systems, OTC pharmaceuticals, healthcare education, and specialized medical networks.

Healthcare can offer structural demand, but it also brings regulatory, quality, reimbursement, and ethical considerations.

Financial Services Add Recurring and Specialist Revenue

Affin Hwang Asset Management, CFGI, Ethniki Insurance, RiverStone Europe, and Hermes show CVC’s interest in financial services and related infrastructure.

These businesses can generate recurring or repeat client relationships when managed well.

Platform Scale Matters

Many CVC acquisitions were large. Ekaterra, Lipton, Cooper, CFGI, Shiseido’s Personal Care Business, Multiversity Group, and Spectrum Medical were all billion-dollar or near-billion-dollar strategic investments.

Large platform deals can create value, but they also require strong execution.

How CVC Capital Acquisitions Fit Its Business Model

CVC Capital Partners’ business model is based on managing private equity, credit, asset, and infrastructure strategies. Acquisitions fit this model because private equity firms seek companies that can grow, improve operations, expand geographically, or become more valuable through better strategic focus.

CVC does not need every company to integrate into one corporate system. Instead, each acquisition must have a clear investment thesis.

A food company may offer brand strength and distribution potential. A healthcare company may offer specialized clinical demand. A financial services company may offer recurring revenue and compliance-driven client needs. A telecom tower business may offer infrastructure-like cash flows. A university or e-learning platform may offer education demand and digital expansion potential.

The common theme is value creation under ownership. CVC Capital Acquisitions reflect a portfolio approach to private equity, not a single-industry corporate consolidation plan.

Financial and Ownership Context

CVC Capital Partners made 48 acquisitions from 2000 to 2025, with total disclosed deal value of about $71.6 billion. The average disclosed acquisition size was approximately $1.5 billion.

The largest listed transactions in the visible record were Ekaterra and Lipton, each listed at $5.1 billion. Other major acquisitions included Cooper at $2.6 billion, CFGI at $1.9 billion, Shiseido’s Personal Care Business at $1.5 billion, Multiversity Group at $1.3 billion, Universidad Alfonso X El Sabio at $1.3 billion, Spectrum Medical at $1.2 billion, and Stock Spirits Group at $1.1 billion.

This financial profile shows that CVC has participated in large-scale buyouts across multiple sectors. However, the firm also completed smaller deals, such as Grupo GSH at $272.0 million, Teneo at $350.0 million, and Affin Hwang Asset Management at $368.0 million.

For analysts, the key issue is whether each acquisition had realistic value creation levers: growth, margin improvement, brand expansion, operational discipline, consolidation potential, or exit optionality.

Competitive Impact of CVC Capital Acquisitions

CVC’s acquisitions can influence competition across several markets.

In food and beverage, acquisitions such as Ekaterra, Lipton, Panzani, Stock Spirits Group, Vivartia, and La Piadineria gave the firm exposure to branded consumer products, restaurant formats, and food processing.

In healthcare, Grupo GSH, Therakos, Spectrum Medical, Cooper, and Universidad Alfonso X El Sabio added exposure to complex therapies, medical systems, OTC healthcare products, and healthcare education.

In financial services, Affin Hwang Asset Management, Ethniki Insurance, RiverStone Europe, CFGI, and Hermes added exposure to asset management, insurance, advisory, risk management, and cash management.

In infrastructure and telecommunications, Irrawaddy Green Towers added telecom tower exposure.

The competitive impact depends on what happens after acquisition. Private equity ownership can support investment, expansion, restructuring, and operational improvement. However, it can also create pressure to deliver performance quickly.

Advantages of the Acquisition Strategy

Broad Sector Diversification

CVC invests across food, healthcare, financial services, manufacturing, education, telecommunications, consumer goods, and consulting.

Strong Platform Potential

Many acquired companies were large platforms that could support growth, international expansion, operational improvement, and future exits.

Exposure to Consumer Brands

Ekaterra, Lipton, Panzani, Stock Spirits Group, Shiseido’s Personal Care Business, Vivartia, and La Piadineria provided exposure to recognizable consumer markets.

Healthcare Growth Opportunities

Grupo GSH, Therakos, Spectrum Medical, and Cooper gave CVC access to specialized medical products, therapies, and healthcare services.

Financial Services Depth

CVC gained exposure to asset management, insurance, finance consulting, cash management, and insurance run-off solutions.

Disadvantages of the Acquisition Strategy

High Valuation Risk

Large acquisitions can be risky if the purchase price is too high or earnings growth does not meet expectations.

Financing and Leverage Risk

Private equity deals can be sensitive to interest rates, debt markets, and refinancing conditions.

Regulatory Exposure

Healthcare, insurance, asset management, telecommunications, education, and food businesses can face regulatory scrutiny.

Consumer Demand Risk

Food, beverage, cosmetics, restaurants, and spirits businesses can be affected by changing consumer preferences, inflation, and competition.

Portfolio Complexity

A broad portfolio across many industries requires deep sector expertise and careful governance.

Case Studies of Major CVC Capital Acquisitions

Ekaterra and Lipton

Ekaterra and Lipton were listed as $5.1 billion acquisitions in 2021. Ekaterra was a tea manufacturing and distribution business, while Lipton distributed tea products.

These deals gave CVC major exposure to the global tea market. They also fit the food and beverage theme that appears frequently in the firm’s acquisition history.

The strategic appeal lies in consumer brand recognition, distribution, and the potential to manage a large beverage platform under focused ownership.

Cooper

Cooper was acquired for $2.6 billion in 2021. It is an independent French OTC drug manufacturer and distributor.

This acquisition expanded CVC’s healthcare and manufacturing exposure. OTC medicine can be attractive because it serves recurring consumer health needs through established retail and pharmacy channels.

CFGI

CFGI was acquired for $1.9 billion in 2021. It is a corporate finance and financial consulting firm specializing in complex accounting, reporting, tax, and compliance issues.

This deal gave CVC exposure to specialist financial consulting. Businesses facing complex reporting, tax, and compliance issues often need expert advisory support.

Spectrum Medical

Spectrum Medical was acquired for $1.2 billion in 2022. It is a global leader in perfusion systems and EMR systems.

This acquisition added specialized healthcare technology exposure. Perfusion systems serve critical clinical settings, while EMR systems support medical data and workflow.

Therakos

Therakos was acquired for $925.0 million in 2024. It provides extracorporeal photopheresis immune modulation therapy.

This acquisition strengthened CVC’s healthcare platform in specialized therapy. It also reflects the firm’s willingness to invest in complex medical markets.

Common Mistakes When Analyzing CVC Capital Acquisitions

One common mistake is treating CVC like a corporate acquirer. CVC is a private equity and investment advisory firm, so its acquisitions should be evaluated as investment platforms rather than product-line integrations.

Another mistake is focusing only on the largest deals. Ekaterra, Lipton, and Cooper matter, but smaller deals such as Grupo GSH, Teneo, Hermes, Affin Hwang Asset Management, and La Piadineria also reveal important sector themes.

A third mistake is assuming diversification removes risk. CVC’s portfolio spans many sectors, but each sector carries its own risks.

Another mistake is ignoring regulatory complexity. Healthcare, insurance, asset management, education, telecommunications, and food products all require careful compliance.

Analysts should also avoid assuming private equity ownership automatically improves performance. Value creation depends on management, operations, capital structure, growth strategy, and exit timing.

Lessons for Business Owners and Investors

CVC Capital Partners’ acquisition history offers several lessons.

The first lesson is that private equity firms often prefer companies with strong market positions, recognizable brands, recurring demand, or specialist capabilities.

The second lesson is that food and healthcare can be attractive long-term themes because they serve essential or recurring needs.

The third lesson is that financial services platforms can offer durable client relationships, but they require compliance and risk management.

The fourth lesson is that large platform acquisitions require strong operating discipline.

The fifth lesson is that sector diversification can create opportunity, but it does not remove execution risk.

Key Takeaways

• CVC Capital Partners made 48 acquisitions between 2000 and 2025.
• Total disclosed deal value across CVC Capital Acquisitions is about $71.6 billion.
• The average disclosed acquisition size is approximately $1.5 billion.
• Food and beverage and manufacturing were the leading categories, with 9 deals each.
• Healthcare accounted for 8 deals.
• Financial services accounted for 6 deals.
• Food processing accounted for 5 deals.
• Grupo GSH was the most recent listed acquisition at $272.0 million.
• Ekaterra and Lipton were among the largest listed acquisitions at $5.1 billion each.
• CVC used M&A to invest in food, healthcare, manufacturing, insurance, asset management, education, telecom infrastructure, consulting, and consumer goods.
• Key risks include valuation pressure, leverage, regulation, consumer demand shifts, and portfolio complexity.

Frequently Asked Questions

What are CVC Capital Acquisitions?

CVC Capital Acquisitions are companies acquired by CVC Capital Partners as part of its private equity and investment advisory strategy across food, healthcare, manufacturing, financial services, education, infrastructure, and consumer markets.

How many acquisitions has CVC Capital Partners made?

CVC Capital Partners made 48 listed acquisitions spanning from 2000 to 2025.

What is the total value of CVC Capital acquisitions?

The total disclosed value of CVC Capital acquisitions is about $71.6 billion.

What is CVC Capital’s average acquisition size?

CVC Capital’s average disclosed acquisition size is approximately $1.5 billion.

What was CVC Capital’s most recent acquisition?

The most recent listed acquisition was Grupo GSH, announced on April 15, 2025, for $272.0 million.

What are CVC Capital’s biggest acquisitions?

Among the largest listed acquisitions are Ekaterra and Lipton, each listed at $5.1 billion.

Which sectors does CVC Capital acquire most often?

CVC Capital most often acquires companies in food and beverage, manufacturing, healthcare, financial services, and food processing.

Why did CVC Capital acquire Grupo GSH?

CVC Capital acquired Grupo GSH to gain exposure to highly complex hemotherapy and cell therapy services.

Why are food and beverage deals important to CVC Capital?

Food and beverage deals can offer brand strength, recurring consumer demand, distribution networks, and platform growth potential.

Are CVC Capital acquisitions mainly healthcare deals?

Healthcare is a major theme, but CVC also acquires in food and beverage, manufacturing, financial services, education, telecoms, consulting, and consumer products.

What are the main risks of CVC Capital’s acquisition strategy?

The main risks include high valuations, leverage, regulatory exposure, consumer demand changes, integration complexity, and exit timing.

Do CVC Capital acquisitions guarantee investment returns?

No. Acquisitions can create value, but returns depend on purchase price, financing, management execution, market conditions, operational improvement, and exit opportunities.

Conclusion

CVC Capital Acquisitions show how a global private equity and investment advisory firm used M&A to build exposure across food and beverage, manufacturing, healthcare, financial services, food processing, education, telecommunications, consumer goods, consulting, and medical services.

The firm made 48 listed acquisitions from 2000 to 2025, with total disclosed deal value of about $71.6 billion and an average disclosed deal size of approximately $1.5 billion. Its most recent listed acquisition was Grupo GSH at $272.0 million, while major transactions such as Ekaterra, Lipton, Cooper, CFGI, Shiseido’s Personal Care Business, Multiversity Group, Spectrum Medical, and Stock Spirits Group show the scale of its platform investments.

The pattern is clear. CVC Capital Partners has used acquisitions to back companies with recognizable brands, specialist healthcare capabilities, financial services expertise, consumer demand, and manufacturing scale. Its acquisition record is diversified, but the underlying private equity logic is consistent: buy businesses with value creation potential and support them through focused ownership.

At the same time, private equity M&A carries real risks. Large purchase prices, leverage, regulation, market cycles, operational execution, and exit timing all affect outcomes.

For business owners, investors, and corporate strategy analysts, CVC offers a strong case study in global private equity deal-making. CVC Capital Acquisitions show how buyout firms use capital, sector expertise, and operational discipline to build value across large and diverse markets.

Disclaimer: This article is for informational and educational purposes only. It is not investment advice, financial advice, or a recommendation to buy or sell any security. Always conduct your own research and consider speaking with a qualified financial adviser before making investment decisions.

Read Also: Curtiss-Wright Acquisitions: How Curtiss-Wright Built Its Business Through M&A